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Results: Of 152,762 reports to STIC, 55 involved OD with thiopu-
rines (n = 39), MMF (n = 14), or SIR (n = 2). Of these, 32 were with 
suicidal intent, 19 accidental, and 4 iatrogenic errors. Eleven (31%) 
thiopurine, 4 (31%) MMF, and 1 (50%) SIR ODs had attributable 
symptoms. The majority of symptoms were minor, although 1 case 
of sustained thiopurine OD caused agranulocytosis, 1 case of a 9-fold 
MMF OD caused biphasic hypotension (possibly reflecting entero-
hepatic circulation), and 1 case of SIR OD in a child caused tremor, 
raised liver enzymes, and gastroenteritis. Symptoms were observed 
in patients taking 1.5 and 2.4 times or greater than their usual dose 
(or the maximum licensed dose in patients not usually taking medica-
tion) for thiopurines and MMF, respectively. Decontamination meas-
ures were undertaken in 10 thiopurine ODs (9 activated charcoal, 
1 gastric lavage). The OR for the development of symptoms after 
gastrointestinal decontamination in these ODs was 0.14 (95% CI, 
0.01–1.5) compared with cases without decontamination. Charcoal 
was given primarily to children. The mean age of cases managed 
with charcoal was 8 (10) versus 30 (15) years for cases managed 
without (P < 0.0001).
Conclusion: Acute toxicity with thiopurines appears to only be 
significant with a prolonged exposure to high drug concentrations. 
MMF ODs seem to be well tolerated. Physicians should be aware, 
however, that patients who develop hypotension shortly after oral 
OD may relapse some hours later. It seems that SIR is highly toxic in 
young children even at modest degrees of overdose. Gastrointestinal 
decontamination with activated charcoal appeared to reduce symp-
tom development after overdose of thiopurines. Thiopurine, MMF, 
and SIR OD patterns, outcomes, and management require contin-
ued study and transplant and poisons centers should be encouraged 
to actively seek follow-up data on the cases with which they are 
involved.
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Introduction: Pipamperone (PIP) is a mild to moderately potent buty-
rophenone neuroleptic. Its mechanism of action is thought to be the 
antagonism of serotonin 5-HT2A and dopamine D4 receptors. The 
aim of the study was to analyze the clinical features of PIP poison-
ing because information on patterns of toxicity of this substance in 
overdose is scarce and limited to case reports.
Patients (or Materials) and Methods: Retrospective consecutive 
review of acute PIP monointoxications reported by physicians to the 
STIC between August 1974 and November 2012.
Results: Thirty-two adults, 3 teenagers, and 3 children could be 
included. Mean age of the group with adults and teenagers was 41 
years (range, 14–90), and the ingested dose in this group ranged 
between 60 and 2400 mg (mean, 638). Five (14%) patients remained 
asymptomatic, 21 (60%) showed minor, 8 (22%) moderate, and 1 
severe symptoms according to Poisoning Severity Score. There was 
no fatality. Minor symptoms occurred after ingestion of 60 to 1200 
mg PIP (mean, 578), moderate symptoms after 160 to 2400 mg 
(mean, 950), and severe symptoms after 1200 mg. Signs and symp-
toms predominantly involved the central nervous and the cardiovas-
cular systems (Table). An ECG was available in 20 patients, and 
8 showed a prolonged QTc interval (455–505 ms) after ingestion of 
400 to 1600 mg. A previously healthy woman developed a general-
ized seizure after ingestion of 1600 mg. Coma occurred after intake 
of 1200 mg in an adult, and 360 mg in a 4.5-year-old child. Two 
children (2- and 4-year-old) remained asymptomatic after ingestion 
of 10 and 80 mg, respectively.
Conclusion: The severity of poisoning was related to the ingested 
PIP dose. Overdose was associated mostly with mild to moderate, 
neurologic and cardiovascular signs/symptoms. There was 1 acute 
single convulsive episode, which has not been previously described in 
literature. The remarkable frequency of QTc prolongation deserves 
particular attention, since a case of torsades de pointes has been pre-
viously described.1 The relevance of this phenomenon could increase 
in the near future because a fixed combination of low-dose PIP and 
citalopram, which has also QT prolonging potential, is investigated 
in a Phase III study. Poisoned patients should be monitored for central 
nervous system depression, dysrhythmias and QTc prolongation.
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Introduction: Inhabitants of Melun and vicinities have been exposed 
to a waste incinerator (1974–2002) emitting high concentrations of 
dioxins (226 ng I-TEQ/Nm3) up to 2000-times the maximal recom-
mended values. This constitutes a case of unique and well-identified 
source of pollution. Dioxin (TCDD) is a well-described CYP1A 
inducer in vitro but in vivo studies are, however, rare. CYP1A has 
a role in the activation of some environmental and food-borne car-
cinogens and metabolic ratio of paraxanthine (17X) and caffeine 
(1,3,7-trimethylxanthine, 137X) is used as a measure of its activity. 
The aim of the study was to assess the exposed population through 
Table.  Symptoms/signs with classification according to severity 
(Poisoning Severity Score).
Severity
Symptom/Sign Minor n (%) Moderate n (%) Severe n (%)
Somnolence 15 (39)
Coma 2 (5.2) 2 (5.2)
Dystonic reactions 3 (7.9) 1 (2.6)
Seizures 1 (2.6)
Disorientation 1 (2.6)
Agitation 1 (2.6) 1 (2.6)
Tachycardia 6 (15.8)
Hypotension 5 (13.1) 1 (2.6)
QTc prolongation 8 (18.4) 1 (2.6)
AV block I 1 (2.6)
Xerostomia 3 (7.9)
Gastrointestinal symptoms 3 (7.9)
Urinary retention 1 (2.6)
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an epidemiologic questionnaire and measure CYP1A activity as a 
putative biomarker of chronic exposure to dioxins.
Patients (or Materials) and Methods: Volunteers living in Melun area 
for at least 5 years (between 1974 and 2002) were included in the 
study. A questionnaire was designed to assess source and length of 
exposure, risk and confounding factors, and environmental sources 
of variability in CYP1A activity. The following items were system-
atically assessed: place of habitation, place and type of work, other 
sources of pollution, food questionnaire, smoking, caffeinated drinks 
and alcohol consumption, and medications (CYP1A inhibitors/induc-
ers). They had a full medical history and physical examination with 
a special focus on skin lesions. CYP1A activity was assessed 2 hours 
after the ingestion of a drink containing caffeine through measure-
ment of the ratio (MR) of 17X/137X by liquid chromatography mass 
spectrometry. CYP1A activities were compared with the phenotypes 
of healthy volunteers and to the acute dioxin intoxication of Victor 
Yushchenko described by Sorg et al. (Lancet 2009; 374:1179-85.)
Results: Forty-eight volunteers (age, 11–78) were included in the 
study (25 men, 23 women). A high frequency of dysthyroidism and 
cancer was noticed in the population. Eleven had a history of thy-
roid disease (23%) and 7 (14.5%) had a cancer. Skin lesions were 
described in 13 patients (27%). Mean CYP1A activity of the exposed 
population was comparable to the healthy volunteers (17X/137X 
MR of 0.250 SD 0.08 and 0.273 SD 0.12, respectively). However, 8 
exposed volunteers (16%) had a 17X/137X MR above 0.4, indicating 
that CYP1A is induced (maximal 17X/137X MR of 0.649). CYP1A 
activity was not correlated with the presence of thyroid disease, can-
cer, or skin lesions. After acute dioxin intoxication, CYP1A was more 
strongly induced (maximal 17X/137X MR of 1.9). Induction was still 
persistent 2 years after acute exposure.
Conclusion: A high frequency of dysthyroidism (23%) and cancer 
(14.5%) was noticed in a sample population of Melun area exposed 
chronically to dioxins from a waste incinerator. CYP1A was induced 
in 16% of the population but without significant association with 
thyroid disease, cancer, or skin lesions. After acute dioxin intoxica-
tion, the magnitude of CYP1A induction was 3- to 6-fold higher.
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Introduction: Although accidental poisoning with atypical antipsy-
chotics in children is 1 of the most important causes of morbidity 
after accidental ingestion of medications, the number of studies that 
have assessed the effects of acute exposure to this class of drugs is 
very limited. The aim of this study was to achieve a better char-
acterization of the acute toxicity profile in young children of the 
common atypical antipsychotics clozapine, olanzapine, quetiapine, 
and risperidone.
Patients (or Materials) and Methods: Multicenter retrospective anal-
ysis of cases with atypical antipsychotics intoxication in children 
< 6 years, reported by physicians to German, Austrian, and Swiss 
Poisons Centres between January 1, 2001, and December 31, 2009.
Results: A total of 106 cases of intoxication (31 clozapine, 29 olan-
zapine, 12 quetiapine, and 34 risperidone) were analyzed. Mean age 
was 2.6 years (range, 0.8–5.5). There were 52 (49%) females, 43 
(40.6%) males, and in 11 (10.4%) cases gender was not reported. 
No correlation between age and number of ingested pills was found 
(Spearman correlation coefficient, 0.16). Concerning the number of 
ingested pills, there was no significant difference between males and 
females (Wilcoxon test, P = 0.39). Overall toxicity was rated as severe 
in 2 (1.9%), moderate in 28 (26.4%), and minor in 47 (44.3%) cases 
according to the Poisoning Severity Score. Twenty-eight (26.4%) 
cases were asymptomatic. No fatalities were recorded. Neurological 
and cardiovascular symptoms were predominating. Minor reduc-
tion in vigilance (Glasgow Coma Scale score > 9) (62.3%) was the 
most frequently reported symptom, followed by miosis (12.3%) and 
mild tachycardia (10.4%). Extrapyramidal motor symptoms were 
observed in 1 case (0.9%) after ingestion of 2 mg (0.1 mg/kg) of risp-
eridone. Electrocardiography was performed in 32 (30.2%) children: 
3 (2.8%) showed extrasystoles, and in 1 (0.9%) case a prolonged 
QTc interval (468 ms) was recorded after the ingestion of 150 mg 
(13.6 mg/kg) of quetiapine. For clozapine, the lowest dose causing 
objective symptoms or signs was 0.8 mg/kg, resulting in aggressive-
ness, ataxia, dysarthria, and somnolence; for olanzapine, 0.4 mg/
kg resulting in ataxia and somnolence; for quetiapine, 3.1 mg/kg 
resulting in ataxia and somnolence; and for risperidone, 0.05 mg/kg 
resulting in somnolence and mild tachycardia. In most cases, surveil-
lance and supportive care were sufficient to achieve a good outcome, 
and all children made a full recovery.
Conclusion: Most children poisoned with the atypical antipsychotics 
clozapine, olanzapine, quetiapine, and risperidone had a benign clini-
cal course without sequelae. Extrapyramidal side effects were rare, 
and the only case reported was caused by risperidone. Symptomatic 
patients should be monitored for central nervous system depression, 
and an electrocardiogram should be obtained.
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Introduction: Oranophosphorus compounds are widely used in 
industry, agriculture, and for public health purposes. The aim of 
this work was to study the effect of dimethoate on fertility in adult 
male rats and the possible underlying mechanism of action.
Patients (or Materials) and Methods: The study was conducted on 
healthy, sexually mature male Wistar albino rats weighing between 
250 and 300 g. Animals were assigned randomly into 4 groups, each 
of 6 rats as follows: Group 1, control, orally administered with 1 mL 
of corn oil. Groups 2, 3, and 4 received dimethoate at a dose equiva-
lent to 7, 10.5, and 21 mg/kg body weight, respectively. Commercial 
formulation of dimethoate was used. Radioimmunoassay (RIA) kits 
for determination of testosterone, lutenizing hormone (LH), follicle-
stimulating hormone (FSH), and prolactin hormone. For total cho-
lesterol determination, available kit was used. Fertility test: Each 
male was allowed to undergo mating with 2 females (3–4 months 
old) of proven fertility during the last 10 days of the experiment. 
Serum and organ collections for determination of acetylcholinesterase 
activity and for histopathologic evaluations using light and electron 
microscopic study.
